The day
Friday, October 30, 2026
Fri, Oct 305 min 50 sec
Chapters
- 0:08Worth readingFTI Consulting, Inc, Vistagen Therapeutics, Inc., Citizens Financial Group Inc, Allarity Therapeutics, Inc.
- 2:31Results
- 2:50ReportsAmazon Com Inc, Bank of America Corp, Intel Corp, General Dynamics Corp
- 4:01Insider tradesHilton Worldwide Holdings Inc., Rapport Therapeutics, Inc., Dutch Bros Inc., World Acceptance Corp
- 5:17Officers
- 5:31What else was filed
Transcript
- FCNThird quarter 2026 record revenues of $1.013 billion increased $56.4 million, or 5.9%, compared to revenues of $956.2 million in the prior year quarter.
- VTGNOn October 26, 2026, Vistagen Therapeutics implemented a Board-approved reduction in workforce of approximately 31%, retaining core capabilities for Phase 3 development of fasedienol.
- CFGThe Audit Committee approved changing the Company's independent registered public accounting firm to PricewaterhouseCoopers LLP and dismissing Deloitte & Touche LLP, effective upon completion of Deloitte's audits for fiscal 2026.
- ALLROn October 28, 2026, Allarity Therapeutics terminated the Common Stock Purchase Agreement dated January 28, 2026 with Tumim Stone Capital LLC, effective as of that date.
- ALBOn October 29, 2026, Albemarle Corporation entered into a credit agreement among the Company, the lenders party thereto, and JPMorgan Chase Bank, N.A., as administrative agent.
- CRTDOn October 27, 2026, the Company and C2 Live mutually agreed to terminate the LOI.
- PTHSOn October 30, 2026, Pelthos Therapeutics Inc. agreed to merge with Castle Creek Biosciences, Inc. Castle Creek stockholders will receive 5,200,000 shares of Pelthos common stock.
- USBOn October 29, 2026, U.S. Bancorp filed a Certificate of Designations establishing the Series P Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock with a liquidation preference of $25,000 per share.
- ZDPYOn October 30, 2026, the Company completed the sale of its business and substantially all its assets to BPB Partners, LLC. The stated purchase price is $7,800,000, reduced by indebtedness the buyer elected to assume.
- EDBLOn October 30, 2026, pursuant to the Purchase Contract, the Company completed the acquisition of the Property.
- 66 companies reported results: BrightSpring Health Services, Inc., Carter's Inc, Chevron Corp, OneMain Holdings, Inc., LyondellBasell Industries N.V., ExxonMobil Holdings Corp, Kite Realty Group Trust, nVent Electric plc
- AMZNAmazon Com Inc filed its quarterly report, revenue $201.94B, +12.1%
- BACBank of America Corp filed its quarterly report, revenue $29.96B, +3.2%
- INTCIntel Corp filed its quarterly report, revenue $16.51B, +20.9%
- GDGeneral Dynamics Corp filed its quarterly report, revenue $14.57B, +12.9%
- WKCWorld Kinect Corp filed its quarterly report, revenue $13.27B, +41.3%
- TMOThermo Fisher Scientific Inc. filed its quarterly report, revenue $12.14B, +9.1%
- SNDKSandisk Corp filed its quarterly report, revenue $11.03B, +377.9%
- APHAmphenol Corp filed its quarterly report, revenue $10.23B, +65.1%
- 19 purchases worth $30.24M, 91 sales worth $219.07M
- HLTAt Hilton Worldwide Holdings Inc., Kevin J Jacobs, See Remarks, sold 151,050 shares for $53.80M
- RAPPAt Rapport Therapeutics, Inc., James Healy, Director, bought 969,480 shares for $20.36M
- BROSAt Dutch Bros Inc., Travis Boersma, Executive Chairman of Board, sold 408,023 shares for $17.96M
- WRLDAt World Acceptance Corp, Prescott General Partners LLC, 10% owner, sold 88,324 shares for $15.00M
- DDOGAt Datadog, Inc., Alexis Le-Quoc, Chief Technology Officer, sold 43,224 shares for $12.06M
- BROSAt Dutch Bros Inc., DM Trust Aggregator, LLC, 10% owner, sold 266,000 shares for $11.71M
- 38 companies reported an officer's departure or appointment: Carter's Inc, Genworth Financial Inc, Enact Holdings, Inc., Gorman Rupp Co, Game Your Game Inc., NextCure, Inc.
- 135 6-K, 92 Form 144, 335 Schedule 13G, 17 Schedule 13D, 30 Merger communications, 34 Proxy statements, 15 S-1, 808 Prospectuses